Leap Therapeutics Inc (LPTX)
2.88
-0.12
(-3.84%)
USD |
NASDAQ |
Nov 14, 16:00
2.95
+0.07
(+2.43%)
After-Hours: 18:31
Leap Therapeutics Total Liabilities (Quarterly): 15.64M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 15.64M |
| March 31, 2024 | 10.59M |
| December 31, 2023 | 12.68M |
| September 30, 2023 | 11.04M |
| June 30, 2023 | 11.80M |
| March 31, 2023 | 78.22M |
| December 31, 2022 | 11.49M |
| September 30, 2022 | 12.09M |
| June 30, 2022 | 10.88M |
| March 31, 2022 | 7.344M |
| December 31, 2021 | 10.02M |
| September 30, 2021 | 11.26M |
| June 30, 2021 | 8.056M |
| March 31, 2021 | 7.428M |
| December 31, 2020 | 7.72M |
| September 30, 2020 | 7.406M |
| June 30, 2020 | 7.94M |
| March 31, 2020 | 10.78M |
| December 31, 2019 | 9.197M |
| September 30, 2019 | 8.579M |
| June 30, 2019 | 9.198M |
| Date | Value |
|---|---|
| March 31, 2019 | 9.019M |
| December 31, 2018 | 9.899M |
| September 30, 2018 | 20.50M |
| June 30, 2018 | 22.27M |
| March 31, 2018 | 22.56M |
| December 31, 2017 | 17.94M |
| September 30, 2017 | 5.994M |
| June 30, 2017 | 4.375M |
| March 31, 2017 | 4.612M |
| December 31, 2016 | 106.69M |
| June 30, 2016 | 0.577M |
| December 31, 2015 | 71.55M |
| September 30, 2015 | 2.739M |
| June 30, 2015 | 2.81M |
| March 31, 2015 | 2.821M |
| December 31, 2014 | 2.488M |
| September 30, 2014 | 1.971M |
| June 30, 2014 | 3.195M |
| March 31, 2014 | 2.746M |
| December 31, 2013 | 1.971M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.344M
Minimum
Mar 2022
78.22M
Maximum
Mar 2023
13.77M
Average
10.78M
Median
Mar 2020
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.613M |
| Perspective Therapeutics Inc | 44.92M |
| Protalix BioTherapeutics Inc | 62.96M |
| Electromed Inc | 7.689M |
| Armata Pharmaceuticals Inc | 154.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 81.43M |
| Shareholders Equity (Quarterly) | 65.79M |